
Measles Elimination Review Delayed as Outbreaks Grow and Real-Time Safety Reporting Takes Shape
A Daily Kos Infectious Information update says the measles elimination status review has been moved to November amid outbreaks from unvaccinated travelers, with exposure alerts in Colorado and Sacramento and a Utah surge; Covid and long Covid persist; a dengue vaccine shows strong Phase 3 results; avian flu and a moderately severe influenza season continue; the FDA plans a real-time adverse-event dashboard (AEMS) to replace VAERS/FAERS/AERS, though credibility checks remain unclear. Other notes include rising aspergillosis and human metapneumovirus, concerns over RNA vaccine funding, misinformation impacts, Tylenol use in pregnancy decline, and a WHO warning about health consequences of the Iran war.





